Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Innogen Pharmaceutical’s Shares Soar in Hong Kong Trading Debut

Summary by South China Morning Post
Shares in major biotech companies in Hong Kong have gained an average of 137 per cent in cumulative returns this year.

2 Articles

BloombergBloomberg
Lean Left

Chinese Drugmaker Aiming to Sell Obesity Meds Soars in HK Debut

Guangzhou Innogen Pharmaceutical Group Co., a Chinese biotech firm looking to tap the vast domestic market for obesity drugs, surged as much as 296% in its trading debut in Hong Kong.

·United States
Read Full Article
South China Morning PostSouth China Morning Post
Center

Innogen Pharmaceutical’s shares soar in Hong Kong trading debut

Shares in major biotech companies in Hong Kong have gained an average of 137 per cent in cumulative returns this year.

·Hong Kong
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

South China Morning Post broke the news in Hong Kong on Friday, August 15, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Asia icon

Asia

Guangzhou icon

Guangzhou

Hong Kong City icon

Hong Kong City

News
For You
SearchBlindspotLocal